MedTrace Logo

Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis

NCT06478602 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2026-03-27

Study results available
· View outcomes & findings →

Summary

The study aims to investigate the beneficial effects of fecal transplantation in patients diagnosed with liver cirrhosis (regardless of etiology).

Conditions

Interventions

BIOLOGICAL

Fecal microbiota transplantation

Performing a colonoscopy with fecal microbiota transplantation at the level of the cecum.

Sponsors & Collaborators

  • Cristian Ichim

    lead OTHER

Principal Investigators

  • Victoria Birlutiu, Prof. Dr. · County Clinical Emergency Hospital of Sibiu

  • Adrian Boicean, Prof. Dr. · County Clinical Emergency Hospital of Sibiu

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-05
Primary Completion
2024-12-30
Completion
2025-03-31

Countries

  • Romania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06478602 on ClinicalTrials.gov